Feature Channels: Infectious Diseases

Filters close
Released: 16-Aug-2023 1:10 PM EDT
Racism, Poverty, and Illiteracy Increase the Risk of Contracting and Succumbing to AIDS in Brazil
Barcelona Institute for Global Health, ISGlobal

Social determinants of health —the social conditions in which people grow up, live and work— can influence the risk of contracting AIDS and the mortality associated with the disease.

   
Released: 16-Aug-2023 9:30 AM EDT
Leading Researcher Jane Carlton Joins Bloomberg School of Public Health’s Johns Hopkins Malaria Research Institute as Director
Johns Hopkins Bloomberg School of Public Health

Jane Carlton, PhD, a biologist and leader in the field of comparative genomics, has joined the Johns Hopkins Bloomberg School of Public Health as director of the Johns Hopkins Malaria Research Institute. She assumed the role on August 1.

   
Newswise: Common Wristbands ‘Hotbed’ for Harmful Bacteria Including E. Coli, Staphylococcus
Released: 16-Aug-2023 8:30 AM EDT
Common Wristbands ‘Hotbed’ for Harmful Bacteria Including E. Coli, Staphylococcus
Florida Atlantic University

Routinely cleaning wristbands is generally ignored. New research finds 95 percent of wristbands tested were contaminated. Rubber and plastic wristbands had higher bacterial counts, while gold and silver, had little to no bacteria. Bacteria found were common skin residents of the genera Staphylococcus and Pseudomonas, and intestinal organisms of the genera Escherichia, specifically E. coli. Staphylococcus was prevalent on 85 percent of the wristbands; researchers found Pseudomonas on 30 percent of the wristbands; and they found E. coli bacteria on 60 percent of the wristbands, which most commonly begins infection through fecal-oral transmission.

   
Released: 15-Aug-2023 1:35 PM EDT
Dogs can detect COVID-19 infections faster and more accurately than conventional technology, demonstrating readiness for mainstream medical applications
University of California, Santa Barbara

It’s an idea that has finally gained scientific consensus: Dogs can be a faster, more precise, less expensive — not to mention friendlier — method of detecting COVID-19 than even our best current technology.

Released: 15-Aug-2023 12:35 PM EDT
Mount Sinai Study Among the First to Show That Drugs Targeting the Lung, Rather Than Bacteria, May Prevent Staph Infection in Flu Patients
Mount Sinai Health System

Mount Sinai study among the first to show that drugs targeting the lung, rather than bacteria, may prevent staph infection in flu patients

Released: 14-Aug-2023 4:45 PM EDT
New study charts exposure to SARS-CoV-2 infection in Canada throughout the pandemic
Canadian Medical Association Journal

Most people in Canada now have hybrid immunity against SARS-CoV-2 through a mix of infection and vaccination, new research in CMAJ (Canadian Medical Association Journal) shows.

Released: 14-Aug-2023 1:45 PM EDT
Surprise COVID discovery helps explain how coronaviruses jump species
University of Virginia Health System

Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help scientists better predict how COVID-19 will evolve.

Newswise: Raising awareness of Long Covid ‘blue legs’ symptom
Released: 14-Aug-2023 1:20 PM EDT
Raising awareness of Long Covid ‘blue legs’ symptom
University of Leeds

An unusual case of a Long Covid patient’s legs turning blue after 10 minutes of standing highlights the need for greater awareness of this symptom among people with the condition, according to new research published in the Lancet.

Released: 11-Aug-2023 12:50 PM EDT
Variable patient responses to SARS-CoV-2 infection are mimicked in genetically diverse mice
Jackson Laboratory

Researchers at The Jackson Laboratory have created a panel of genetically diverse mice that accurately model the highly variable human response to SARS-CoV-2 infection.

   
Newswise: Another Summer, Another COVID-19 Surge
Released: 10-Aug-2023 6:30 PM EDT
Another Summer, Another COVID-19 Surge
Cedars-Sinai

This summer, like every summer since COVID-19 arrived on the scene, the U.S. is experiencing a spike in infections and hospitalizations.

Newswise: The Most Important Question About Long COVID
Released: 10-Aug-2023 6:05 PM EDT
The Most Important Question About Long COVID
Harvard Medical School

What causes long COVID? More than three years after the start of the pandemic, this remains the most bedeviling question about a mystifying syndrome estimated to affect some 65 million people globally — an epidemic in its own right with no clear end in sight.

Newswise: Can Better Data Predict Opioid Overdoses and Slow Infectious Disease Rates?
Released: 10-Aug-2023 2:50 PM EDT
Can Better Data Predict Opioid Overdoses and Slow Infectious Disease Rates?
Tufts University

Tufts University School of Medicine teams and collaborators are running multiple projects that seek to reduce overdoses and the spread of infections, such as HIV and hepatitis C, in people who use drugs

Released: 10-Aug-2023 1:25 PM EDT
Study Reveals Patients Hospitalized with COVID-19 Faced Nearly Twice the Rates of Death After Discharge As Patients with Flu
Beth Israel Deaconess Medical Center

Researchers demonstrate that among individuals who were admitted to the hospital with COVID-19 and were discharged alive, the risk of post-discharge death was nearly twice that observed in those who were discharged alive from an influenza-related hospital admission.

Released: 10-Aug-2023 1:10 PM EDT
Gastrointestinal viruses all but disappeared during COVID—but surged back two years on
American Society for Microbiology (ASM)

Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but disappeared from California communities, and remained at very low levels for nearly 2 years.

Released: 10-Aug-2023 11:05 AM EDT
"Get back to where you once belonged!" Back-to-School stories for media
Newswise

It's that time of year again. For media working on stories about the seasonal return to school, here are the latest features and experts in the Back-To-School channel on Newswise.

     
Newswise: Guiding Vaccine Development with Machine Learning
Released: 10-Aug-2023 10:35 AM EDT
Guiding Vaccine Development with Machine Learning
Pacific Northwest National Laboratory

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

   
Newswise:Video Embedded traditional-healers-in-rural-mpumalanga-help-diagnose-hiv
VIDEO
Released: 10-Aug-2023 8:55 AM EDT
Traditional healers in rural Mpumalanga help diagnose HIV
University of the Witwatersrand, Johannesburg

An initiative of Wits University’s MRC/Wits Agincourt Research Unit, the Traditional Healers Project convened two ‘open houses’ at local primary healthcare facilities – Rolle Clinic and Thulamahashe Community Health Centre in rural Bushbuckridge, Mpumalanga – in March 2023.

Newswise: Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder
Released: 10-Aug-2023 8:00 AM EDT
Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder
University of North Carolina School of Medicine

The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.

Newswise: A new look inside Ebola's
Released: 9-Aug-2023 4:05 PM EDT
A new look inside Ebola's "viral factories"
La Jolla Institute for Immunology

The study, led by scientists at La Jolla Institute for Immunology (LJI), reveals the inner workings of viral factories, clusters of viral proteins and genomes that form in host cells.

   
Released: 9-Aug-2023 11:20 AM EDT
High-speed train tech used to detect airborne viruses – new research
Michigan State University

Researchers from University of British Columbia and Michigan State University have invented a system that can quickly and inexpensively detect airborne viruses using the same technology that enables high-speed trains.

Newswise: The Wistar Institute Recruits Virology Expert Alexander Price, Ph.D., to Cancer Center
9-Aug-2023 8:45 AM EDT
The Wistar Institute Recruits Virology Expert Alexander Price, Ph.D., to Cancer Center
Wistar Institute

The Wistar Institute is pleased to announce the appointment of Alexander Price, Ph.D., as assistant professor in the Gene Expression and Regulation Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute.

Released: 8-Aug-2023 4:05 PM EDT
تقليل خطورة العَدوى المنقولة جنسيًا
Mayo Clinic

العَدوى المنقولة جنسيًا (الأمراض المنقولة جنسيًا) آخذة في الارتفاع في الولايات المتحدة وحول العالم. ذكرت منظمة الصحة العالمية أن أكثر من مليون إصابة جديدة من العَدوى المنقولة جنسيًا تحدث يوميًا - معظمها بدون أعراض.

Released: 8-Aug-2023 3:05 PM EDT
Mind what you eat and drink. Food and Water Safety stories for media.
Newswise

The latest headlines from the Food and Water Safety channel on Newswise.

       
Released: 8-Aug-2023 3:05 PM EDT
Redução dos riscos de doenças sexualmente transmissíveis
Mayo Clinic

As doenças sexualmente transmissíveis (DSTs) continuam a aumentar nos EUA e ao redor do mundo. A Organização Mundial da Saúde relata que mais de 1 milhão de novas doenças sexualmente transmissíveis são adquiridas diariamente, sendo que a maioria delas é assintomática.

Released: 8-Aug-2023 3:05 PM EDT
Reducir los riesgos de infecciones de trasmisión sexual
Mayo Clinic

Las infecciones de trasmisión sexual (ITS) siguen aumentando en los EE. UU. al igual que en el resto del mundo. Según la Organización Mundial de la Salud, hay más de un millón de nuevas infecciones de trasmisión sexual al día, la mayoría de las cuales son asintomáticas.

Released: 8-Aug-2023 12:05 PM EDT
Modulating type 1 Interferon may expand treatment options for COVID-19
Emory Health Sciences

In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.

Newswise: The Wistar Institute Appoints Life Sciences Consultant and Entrepreneur Joy Taylor to its Board of Trustees
Released: 8-Aug-2023 11:10 AM EDT
The Wistar Institute Appoints Life Sciences Consultant and Entrepreneur Joy Taylor to its Board of Trustees
Wistar Institute

The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Joy Taylor to its Board of Trustees. Taylor is CEO of EastEdge Consulting Services, a Pennsylvania-based management consulting firm focused on organizational and operational improvement.

   
Released: 8-Aug-2023 3:05 AM EDT
Two top Black physicians likely knew of the Tuskegee syphilis study in progress in the 1960’s but did not object, asserts Dr. Leslie Norins, former VD lab director at CDC
OpEdist LLC

A CDC insider's recollections from 60 years ago, plus circumstantial evidence, indicate the Tuskegee syphilis study was not kept secret from some top Black physicians as it progressed.

Not for public release

This news release is embargoed until 7-Aug-2023 5:00 PM EDT Released to reporters: 1-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 4-Aug-2023 10:40 AM EDT
An adjuvanted intranasal vaccine for COVID-19 protects both young and old mice
Michigan Medicine - University of Michigan

A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops COVID infection in both young and old mice.

Released: 2-Aug-2023 1:25 PM EDT
One year post-COVID-19 mass vaccination, immunization coverage is higher among those eligible for priority vaccination
University of Tsukuba

At the beginning of the mass vaccination against COVID-19 infection, the government had to determine eligibility for priority vaccination.

Newswise:Video Embedded novel-molecules-burst-virus-bubbles-to-fight-infection
VIDEO
Released: 2-Aug-2023 12:45 PM EDT
Novel molecules fight viruses by bursting their bubble-like membranes
New York University

Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers?

   
Newswise: Rising cases of leprosy in Florida raise questions
Released: 2-Aug-2023 10:55 AM EDT
Rising cases of leprosy in Florida raise questions
University of Miami

Dr. Andrea Maderal, a specialist in complex dermatology at the Miller School of Medicine, addresses queries about a recent spike in leprosy cases in Central Florida.

31-Jul-2023 12:05 PM EDT
Genetic variant linked to lower levels of HIV virus in people of African ancestry
University of Cambridge

An international team of researchers has found a genetic variant that may explain why some people of African ancestry have naturally lower viral loads of HIV, reducing their risk of transmitting the virus and slowing progress of their own illness.

28-Jul-2023 8:00 AM EDT
Mimicking the body’s own defenses to destroy enveloped viruses
American Chemical Society (ACS)

Viruses often mutate or hide themselves within cells. But by mimicking the way the immune system naturally deals with invaders, researchers reporting in ACS Infectious Diseases have developed a “peptoid” antiviral therapy that effectively inactivates three viruses in lab tests.

   
Newswise: Extroverts More Likely to Resist Vaccines, Study Shows
Released: 2-Aug-2023 5:00 AM EDT
Extroverts More Likely to Resist Vaccines, Study Shows
University of Texas at El Paso

Which types of personalities were more hesitant about COVID-19 vaccination during the pandemic’s peak? Extroverts — according to a new study on more than 40,000 Canadians.

   
Released: 1-Aug-2023 5:30 PM EDT
Three doses of COVID-19 vaccine leads to catch-up antibody responses among the particularly vulnerable
University of Gothenburg

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

27-Jul-2023 3:05 PM EDT
The Key to Battling a Pathogen Hides in Its Genome
Northern Arizona University

The availability, speed and effectiveness of genomic sequencing increased dramatically during the pandemic, as scientists worldwide rushed to find ways to track and predict the virus’s movement and evolution. It also was critical in the development of effective vaccines. In an essay published today, two NAU biologists argue that building on this momentum is critical in society’s response to future pandemics, but it requires significant collaboration and investment now, before the next pathogen is threatening society.

   
Released: 1-Aug-2023 9:05 AM EDT
COVID-19 Vaccines: What Parents Need to Know Now
Children's Hospital Los Angeles

The coronavirus pandemic is no longer a national emergency, but the virus that causes COVID-19 isn’t gone—and neither is the risk of getting the disease. For parents, navigating when to get their child vaccinated and knowing how to best protect their child from COVID-19 can be complicated. We spoke to Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control at Children’s Hospital Los Angeles, to get an update on the latest COVID-19 vaccine information and precautions.

Released: 31-Jul-2023 12:15 PM EDT
UTHealth Houston set to enroll patients for two long COVID clinical trials through NIH
University of Texas Health Science Center at Houston

Two clinical trials that will evaluate drugs, biologics, medical devices, and other therapies for long COVID that are sponsored by the National Institutes of Health (NIH) will launch at UTHealth Houston.

Released: 31-Jul-2023 12:00 PM EDT
Duke Clinical Research Institute launches long COVID trials through NIH RECOVER Long COVID Initiative
Duke Clinical Research Institute

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and other therapies.

Newswise: Protein Inhibits Development of COVID-19 in Live Animals
Released: 31-Jul-2023 11:05 AM EDT
Protein Inhibits Development of COVID-19 in Live Animals
UT Southwestern Medical Center

A mammalian protein previously shown by UT Southwestern microbiologists to inhibit the virus that causes COVID-19 in cell culture also protected live mouse models, significantly limiting infection in the lung cells and diminishing the symptoms. The findings, published in Nature Microbiology, could lead to new strategies to treat COVID-19, which still infects thousands and kills hundreds in the U.S. every week.

   
Newswise: Mutation accessibility fuels influenza evolution
28-Jul-2023 12:30 PM EDT
Mutation accessibility fuels influenza evolution
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital showed that fixed mutations within a viral population most likely stem from how easy it is to acquire that mutation (i.e., mutation accessibility) rather than just its benefit.

Newswise: Alternative cellular ‘fuels’ boost immunity
Released: 28-Jul-2023 11:05 AM EDT
Alternative cellular ‘fuels’ boost immunity
Van Andel Institute

A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators.

Newswise: New Resource Harmonizes 16S and Shotgun Sequencing Data for Microbiome Research
26-Jul-2023 3:10 PM EDT
New Resource Harmonizes 16S and Shotgun Sequencing Data for Microbiome Research
University of California San Diego

UC San Diego scientists debut Greengenes2, a massive reference database that could be used to reconcile years of microbiome studies.

Newswise: LJI and Kyowa Kirin launch immunology fellowship program
Released: 27-Jul-2023 2:55 PM EDT
LJI and Kyowa Kirin launch immunology fellowship program
La Jolla Institute for Immunology

Support for early career researchers is about to get a major boost, thanks to a new fellowship fund established by leaders at La Jolla Institute for Immunology (LJI) and Japan-based global pharmaceutical corporation, Kyowa Kirin, Inc.

   
Released: 27-Jul-2023 11:20 AM EDT
UV disinfection in the treatment management of SARS-CoV-2 Omicron variants
Nagoya City University

The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its new variants has created a need for effective disinfection technologies to protect against harmful pathogens. While vaccines offer some protection, their effectiveness against future variants is uncertain. Therefore, additional strategies are important during the pre-vaccine stage.



close
4.24064